EMOL Health, a data aggregation company for community oncology practices, Ajeet Gajra, MD, and Pharmacosmos (G1 Therapeutics) are proud to announce that their abstract has been accepted for presentation at the 2025 NCCN Annual Conference to be held in Orlando, March 28-30. The poster will present findings on Myelosuppression and Healthcare Utilization in Community Oncology Patients with Limited-Stage Small Cell Lung Cancer (LS-SCLC) Receiving First-Line Therapy with or without Trilaciclib.
NCCN 2025
